EICHOR
● Active Not Recruiting
A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)
Condition: Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy · Sponsor: Cytokinetics
About this study
This clinical trial will study the effects of aficamten (versus placebo) on the quality of life, exercise capacity, and clinical outcomes of patients with non-obstructive hypertrophic cardiomyopathy.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (180)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| UC San Diego Health - Sulpizio Cardiovascular Center | La Jolla, California, United States | — |
| Keck Medical Center of USC (Outpatient Clinic) | Los Angeles, California, United States | — |
| Cedars-Sinai Medical Center (Smidt Heart Institute) | Los Angeles, California, United States | — |
| UCLA Medical Center Cardiovascular Clinic | Los Angeles, California, United States | — |
| University of California San Francisco | San Francisco, California, United States | — |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Torrance, California, United States | — |
| Yale New Haven Hospital | New Haven, Connecticut, United States | — |
| MedStar Washington Hospital Center | Washington D.C., District of Columbia, United States | — |
| Holy Cross Medical Group - Cardiology Associates | Fort Lauderdale, Florida, United States | — |
| Investigational Drug Services, AdventHealth Orlando | Orlando, Florida, United States | — |
| Emory Clinic | Atlanta, Georgia, United States | — |
+ 168 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06081894